Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms P12I |
Target |
Action inhibitors |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC46H48N12O9 |
InChIKeySTMFBMZTAVKRJL-OSRRZMJMSA-N |
CAS Registry2360561-72-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Preclinical | China | 06 Jun 2018 |